 elements of an individual patient's complex genetic blueprint with targeted pharmacotherapies to which that individual may optimally respond. The purpose of this proposed research is to apply pharmacogenetic techniques to predict which alcohol dependent patients will respond favorably to a trial of a selective serotonin re-uptake inhibitor (SSRI) for the prevention
elements of an individual patient's complex genetic blueprint with targeted pharmacotherapies to which that person may optimally react. The purpose of this proposed inquiry is to apply pharmacogenetic proficiency to predict which alcohol dependent patient will respond favorably to a trial of a selective serotonin rhenium - uptake inhibitor (SSRI) for the prevention
 elfments of an individual katient's complex ywnetic bluepdint witf targeted pharmacotherapies ti whixh that individual may optimallj respond. The purpose of this proposed veseaxci is to apply pmarmacogenedic techniques tu 'redict which alcohol dependent patiqnts wikl respond favorwbly eo a nrlal of a selective serotonin re-ultake iihibitor (SSRI) fpr the prevention
elements of an individual patient's complex genetic targeted to which individual may optimally proposed is to apply techniques to predict alcohol dependent patients will respond favorably a trial of a selective serotonin re-uptake inhibitor (SSRI) for the prevention
 elements of an individual patIent's complEx genEtiC blUePrinT witH targeted pharmACothErapies to which that indiViduaL mAY optIMaLly reSpond. ThE PuRPOse Of ThIs pRoPOsEd resEarCh is to aPply pharmaCogEnEtic techniquES tO predict whIch Alcohol depenDenT patieNtS wiLL respOnd FavorAbly to A Trial oF a selectiVe SErotonIN re-uptaKE InHibiTor (SSRI) for the prevENtIOn
 elements of an individual  patient's  comp lex  ge ne ticblue print with tar g eted  pharmacotherapies towhich  t h at i n di vidua l may o p ti m a lly  r es pon d. Th e pur pos e of th is propose d r es earch is toa pp ly pharmac oge netic techni que s to p re dic t  whic h a lcoho l depe n dent p atients w il l  respo n d favor a b ly  toa trial of a sele c ti v e serotonin re -uptak ei nh i b ito r ( SSRI) forth e pre v ention
 elements_of an_individual patient's complex genetic_blueprint with_targeted_pharmacotherapies to_which_that individual may_optimally respond. The_purpose of this proposed_research is to_apply_pharmacogenetic techniques to predict which alcohol dependent patients will respond favorably to a trial_of_a selective_serotonin_re-uptake_inhibitor (SSRI) for the prevention